liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Dept of Pulmonology, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERES Barcelona, Barcelona, Spain.
Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA.
Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Show others and affiliations
2018 (English)In: ERJ Open Res, E-ISSN 2312-0541, Vol. 4, article id 00028-2018Article in journal (Refereed) Published
Abstract [en]

The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empirical treatment, response to treatment, new antibiotics or new forms of antibiotic administration, and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent. The European Respiratory Society (ERS) launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine (ESICM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), were invited to participate and appointed their representatives. The Latin American Society of Thoracic Diseases (ALAT) was also invited to participate. This manuscript summarises the evidence and recommendations of these international guidelines on HAP and VAP.

Place, publisher, year, edition, pages
2018. Vol. 4, article id 00028-2018
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-146263DOI: 10.1183/23120541.00028-2018OAI: oai:DiVA.org:liu-146263DiVA, id: diva2:1195527
Available from: 2018-04-05 Created: 2018-04-05 Last updated: 2018-04-23

Open Access in DiVA

fulltext(357 kB)116 downloads
File information
File name FULLTEXT01.pdfFile size 357 kBChecksum SHA-512
b9962ad3a043c63defc5538657e630a660f0872052439b414e34e7f270d16c69ae7e5a685c8fdac284366c2870512410e304cebfb5634171e7dc20fa22059c87
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Hanberger, Håkan
By organisation
Division of Microbiology and Molecular MedicineFaculty of Medicine and Health SciencesDepartment of Infectious Diseases
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 116 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 375 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf